Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Kovina Therapeutics logo — Kovina Therapeutics is a preclinical stage biotechnology com...

Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics

Founded 2020 5 employees Grant Total: $2.58M Biotechnology, Health and Wellness

General Information

Company Name Kovina Therapeutics
Founded Year 2020
Employees 5
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

Get notified when Kovina Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics. The company, founded in 2020, aims to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV). Their efforts focus on the Biotechnology and Health and Wellness industries. In November 2022, they received a $275.00K grant investment from the National Institute of Dental and Craniofacial Research (NIDCR).

Taxonomy: preclinical stage, antiviral therapeutics, cancer treatment, HPV, non-surgical treatment, medical research, oncology, pharmaceuticals, viral infections

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1 •••• •••• 01 Nov 2022
Grant •••••• 1 •••• •••• 12 Sep 2022
Grant •••••• 1 •••• •••• 27 Jun 2022
Seed Round •••••• 3
Investor Investor Investor
20 Oct 2021

Kovina Therapeutics Alternatives & Competitors

Kovina Therapeutics vs
DermBiont, Inc.
DermBiont, Inc. United States

Advancing targeted topical therapeutics for dermatological indications

Series A
18 employees
Biotechnology, Health Care
Kovina Therapeutics vs
AIRNA
AIRNA United States

The next generation of RNA editing therapeutics

Series B
84 employees
Biotechnology, Health Care
Kovina Therapeutics vs
Pear Therapeutics
Pear Therapeutics United States

The leader in Prescription Digital Therapeutics

Post Ipo Equity
36 employees
Biotechnology, Digital Health

FAQ About Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics
Kovina Therapeutics was founded in 2020.
Kovina Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Kovina Therapeutics has approximately 5 employees.
Kovina Therapeutics has completed 4 funding rounds, raising a total of $2.58M. The latest funding stage is Grant.
Top alternatives and competitors to Kovina Therapeutics include DermBiont, Inc., AIRNA, Pear Therapeutics, Atom Therapeutics, Nobias Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kovina Therapeutics and DermBiont, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Kovina Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy